• LAST PRICE
    114.1800
  • TODAY'S CHANGE (%)
    Trending Up0.5000 (0.4398%)
  • Bid / Lots
    54.7600/ 1
  • Ask / Lots
    174.0000/ 1
  • Open / Previous Close
    111.7100 / 113.6800
  • Day Range
    Low 111.4074
    High 118.3900
  • 52 Week Range
    Low 102.0100
    High 219.7500
  • Volume
    200,427
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 113.68
TimeVolumeLGND
09:32 ET3958111.4074
09:33 ET5000111.6484
09:42 ET100112.83
09:48 ET272113.4132
09:50 ET100114.625
10:02 ET222114.82
10:04 ET2422114.11
10:13 ET600113.66
10:15 ET1603114.26
10:20 ET100114.43
10:26 ET200114.75
10:31 ET900116.075
10:33 ET800116.24
10:38 ET100116.99
10:40 ET100116.83
10:42 ET100117.22
10:45 ET600115.7904
10:51 ET800117.64
10:54 ET200117.345
10:56 ET100117.58
10:58 ET150118.355
11:00 ET200116.89
11:02 ET100117.145
11:03 ET100116.68
11:05 ET100116.75
11:07 ET300117.8405
11:09 ET2500117.4739
11:12 ET300117.25
11:20 ET100116.84
11:21 ET200116.57
11:23 ET700116.99
11:27 ET200116.82
11:30 ET600116.76
11:32 ET200116.43
11:34 ET300116.89
11:38 ET400115.97
11:48 ET100115.325
11:50 ET3289115
11:52 ET400115.77
11:54 ET100116.17
12:10 ET200116.16
12:12 ET100115.95
12:14 ET100115.05
12:17 ET1391115
12:19 ET3225115.1077
12:24 ET500115.67
12:30 ET100116.17
12:35 ET100116.77
12:37 ET100117
12:50 ET100117.135
12:51 ET117116.5129
12:55 ET400116.64
01:00 ET600117.085
01:02 ET1600116.4501
01:04 ET100116.78
01:09 ET100116.41
01:27 ET100115.21
01:29 ET1330115.07
01:31 ET358115.0646
01:33 ET100115.31
01:38 ET100115.2
01:42 ET1488115.27
01:44 ET831115.415
01:49 ET100115
01:51 ET315115.48
01:54 ET100115.18
01:56 ET449115.2506
01:58 ET100115.31
02:05 ET100115
02:09 ET100114.93
02:14 ET8298115.35
02:23 ET100115.44
02:25 ET110115.45
02:27 ET600114.87
02:30 ET2100115.31
02:36 ET200114.84
02:38 ET100115.33
02:39 ET200115.33
02:41 ET100115.49
02:48 ET800115.12
02:50 ET200115.15
02:54 ET2817115.01
02:56 ET100115
02:57 ET200114.78
03:01 ET300114.88
03:03 ET1100115.11
03:06 ET197115.2
03:08 ET1879115
03:10 ET304115.01
03:12 ET2609114.82
03:14 ET200114.56
03:15 ET115114.3501
03:17 ET200114.74
03:24 ET200115.5597
03:28 ET400115.35
03:30 ET420115.15
03:33 ET500115.39
03:35 ET446115.27
03:37 ET5373115.65
03:39 ET775115.9
03:42 ET300116.05
03:44 ET2200116.545
03:46 ET600115.32
03:48 ET6870115
03:50 ET300115.29
03:51 ET1198114.92
03:55 ET1816114.81
03:57 ET4982114.74
04:00 ET46904114.18
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLGND
Ligand Pharmaceuticals Inc
1.9B
28.6x
---
United StatesCDNA
CareDx Inc
2.0B
-106.6x
---
United StatesNKTR
Nektar Therapeutics
2.0B
-4.0x
---
United StatesVCYT
Veracyte Inc
1.9B
-23.7x
---
United StatesAGIO
Agios Pharmaceuticals Inc
1.6B
-5.4x
---
United StatesTVTX
Travere Therapeutics Inc
1.6B
-5.6x
---
As of 2022-01-22

Company Information

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company. The Company is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's technology includes Captisol Technology, OmniAb Technologies (OMT), Icagen Ion Channel Technology Platform, Pelican Expression Technology platform and Liver Targeting Prodrug (LTP) Technology to assist companies in their work toward securing prescription drug and biologic approvals. It has partnerships and license agreements with over 130 pharmaceutical and biotechnology companies and over 300 programs that are in various stages of commercialization, development or research and are fully funded by its collaboration partners and licensees. Its partners and licensees have programs in clinical development targeting seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

Contact Information

Headquarters
3911 Sorrento Valley Blvd Ste 110SAN DIEGO, CA, United States 92121-1402
Phone
858-550-7500
Fax
302-636-5454

Executives

Non-Executive Independent Chairman of the Board
John Kozarich
President, Chief Operating Officer
Matthew Foehr
Chief Executive Officer, Director
John Higgins
Chief Financial Officer, Executive Vice President - Finance
Matthew Korenberg
Senior Vice President, General Counsel, Secretary
Charles Berkman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.9B
Revenue (TTM)
$274.7M
Shares Outstanding
16.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.14
EPS
$4.00
Book Value
$44.12
P/E Ratio
28.6x
Price/Sales (TTM)
6.9
Price/Cash Flow (TTM)
16.0x
Operating Margin
25.55%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.